VectivBio_Logo_RGB_Color.png
VectivBio Announces Closing of Comet Therapeutics Acquisition
September 21, 2021 07:15 ET | VectivBio AG
BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
logo color s and clearside.jpg
Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD Patients
September 21, 2021 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Signs Renewable Energy Agreement With Georgia Power
September 21, 2021 07:00 ET | Recro Pharma, Inc.
EXTON, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Mesa Air Group Logo (black background).png
Mesa Air Group Announces New Chief Financial Officer
September 21, 2021 07:00 ET | Mesa Air Group, Inc.
PHOENIX, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) Mesa Airlines named Torque Zubeck as its new Chief Financial Officer. Zubeck has been working with Mesa since February...
Versus Logo.png
Versus Systems, represented by L5 Innovations, Will Power Fan Engagement at 2021 Military Bowl presented by Peraton
September 21, 2021 07:00 ET | Versus Systems Inc.
LOS ANGELES, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) announced today that the company will bring new and unique fan engagement opportunities...
lyra logo.jpg
Lyra Therapeutics Announces Publication of Positive LANTERN Results in the International Forum of Allergy & Rhinology
September 21, 2021 07:00 ET | Lyra Therapeutics
LYR-210 is the First Drug-Eluting Product Candidate to Demonstrate Statistically Significant Symptom Improvement for Six Months with a Single Administration in Surgically Naïve Chronic Rhinosinusitis...
Picture2.jpg
ASLAN Pharmaceuticals Establishes Scientific Advisory Board Chaired by Distinguished Dermatology Expert Dr Lawrence Eichenfield
September 21, 2021 07:00 ET | ASLAN PHARMACEUTICALS LIMITED
MENLO PARK. Calif. and SINGAPORE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
LGI Homes Opens New Section at Vacek Country Meadows in Richmond, Texas
September 21, 2021 07:00 ET | LGI Homes, Inc.
RICHMOND, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced the company’s return to Vacek Country Meadows in Richmond, Texas, where the builder is constructing...
BioCryst.jpg
BioCryst to Present at 2021 Cantor Virtual Healthcare Conference
September 21, 2021 07:00 ET | BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the 2021 Cantor Virtual Healthcare...
ORIC Logo_RGB.png
ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor
September 21, 2021 06:30 ET | ORIC Pharmaceuticals
SOUTH SAN FRANCISCO and SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...